A multicenter, randomized, double-blind, parallel-group placebo and pramipexole controlled study to assess efficacy and safety of SLV308 monotherapy in the treatment of patients with early stage Parkinson's Disease. - ND A multicenter, randomized, double-blind, parallel-group placebo and pramipexole controlled study to ...
A multicenter, randomized, double-blind, parallel-group placebo and pramipexole controlled study to assess efficacy and safety of SLV308 monotherapy in the treatment of patients with early stage Parkinson's Disease. - ND A multicenter, randomized, double-blind, parallel-group placebo and pramipexole controlled study to ...